STX-001(Supercede Therapeutics)

N/A

Report date: 2024/07/05 14:34:20
NME

Base Information

Drug NameSTX-001(Supercede Therapeutics)
Drug Alias NameSTX-001(Supercede Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor type-2 inhibitors
TargetsActivin receptor type-2
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSupercede Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSupercede Therapeutics IncFudan UniversityEast China Normal University
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A